Barrett & Company, Inc. Organogenesis Holdings Inc. Transaction History
Barrett & Company, Inc.
- $211 Billion
- Q1 2024
A detailed history of Barrett & Company, Inc. transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Barrett & Company, Inc. holds 1,100 shares of ORGO stock, worth $2,926. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,100
Previous 1,100
-0.0%
Holding current value
$2,926
Previous $4.5 Million
30.56%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ORGO
# of Institutions
129Shares Held
56.3MCall Options Held
55.3KPut Options Held
22.2K-
Morgan Stanley New York, NY11.5MShares$30.7 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT9.57MShares$25.5 Million2.22% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$13.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.54MShares$9.4 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3MShares$7.98 Million0.03% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $348M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...